Paxlovid: How a new oral drug against COVID-19 was designed
Despite progress with vaccinations, the highly contagious Omicron variant has caused cases to surge. Along with other UK approved drugs such as Merck’s Molnupiravir, Pfizer’s oral treatment, Paxlovid, could be a useful tool for doctors to treat patients.
Two suspected Omicron cases identified at Pembroke
“The UK Health Security Agency (UKHSA) has identified two suspected cases of the Omicron variant in people associated with Pembroke College, according to an email from Pembroke to their students."
